Lisata Therapeutics Announces One-for-Fifteen Reverse Stock Split
Lisata Therapeutics (LSTA) has officially announced a one-for-fifteen reverse stock split of its common stock. This corporate action will significantly reduce the company's total outstanding shares from approximately 10.8 million to roughly 0.7 million. The split-adjusted trading is scheduled to commence on the Nasdaq at market open on November 23, 2026. The company will continue to trade under its existing ticker symbol, "LSTA."

Topics: Nasdaq reverse stock split share reduction